Concepedia

Author

Scott Z. Fields

Royal Marsden Hospital

Also Known As

S Fields, S Z Fields, S. FIELDS, S. Fields, S. Z. Fields, S.Z Fields, S.Z. Fields, Scott Fields, Scott Z Fields, Scott Z. Fields

66

Publications

2.8K

Citations

22

H-Index

52

Concepts

All Affiliations

Royal Marsden HospitalNew FrontierVertex Pharmaceuticals (United States)Syracuse UniversitySouth College
SZ

About

Scott Z. Fields is an author at Royal Marsden Hospital specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

814

2

Health Sciences

6

6

168

3

Biochemistry

2

2

181

4

Natural Sciences

1

1

158

5

Biology

1

1

96

Scott Z. Fields

×

29

Publications

2.7K

Citations

21

H-Index

YearCitations

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd,

Journal of Clinical Oncology

1999

943

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

M. A. Bookman, Henric Malmström, Giorgio Bolis,

Journal of Clinical Oncology

1998

334

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas,

Clinical Cancer Research

2004

226

Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.

James E. Gervasoni, Scott Z. Fields, Sindu Krishna,

PubMed

1991

158

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer

Martin Gore, Amit M. Oza, Gordon Rustin,

European Journal of Cancer

2002

110

Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes.

Huimin Chung, Cathy Shea, Scott Z. Fields,

The EMBO Journal

1990

96

Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer

Martin Gore, W ten Bokkel Huinink, James Carmichael,

Journal of Clinical Oncology

2001

93

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.

A. A. Miller, Jeffrey B. Hargis, Rogério Lilenbaum,

Journal of Clinical Oncology

1994

83

Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients.

Alessandra Cesano, Stephen Lane, Ronald F. Poulin,

International Journal of Oncology

1999

67

Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours

C J Gerrits, Howard A. Burris, Jan H.M. Schellens,

European Journal of Cancer

1998

61

Page 1